Search

Osteoarthritis Therapeutics Market

Osteoarthritis Therapeutics Market Size by Drug Type (Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids), Anatomy (Knee, Hip, Hand, Small Joints), Route of Administration, Distribution Channel, Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2024 to 2033

Base Year: 2023 Historical Data: 2020-22
  • Report ID: TBI-12565
  • Published Date: Aug, 2024
  • Pages: 231
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global osteoarthritis therapeutics market is expected to reach USD 21.77 billion by 2033, at a CAGR of 8.35% during the forecast period 2024-2033. Increasing prevalence of osteoarthritis disease across the globe is propelling the growth of osteoarthritis therapeutics market. Osteoarthritis is mostly found in older people, and it is one of the driving factors for the growth of the market.

Market Overview:

Osteoarthritis also called as wear and tear arthritis is one of the most common types of arthritis. It is a progressive disorder where when the smooth cushion between bones breaks down where joints become painful, swollen, and hard to move. The osteoarthritis can happen to any joints, but it mainly occurs in the joints of the knee, hip, and hand joints. The incident of developing osteoarthritis in the knee over a lifetime is about 45%. It is a chronic disorder and worsens with the increasing age. It commonly starts in the age of 50s and happens more in women than men. Apart from the age factor, the disorder is also associated with various factors, including gender, obesity, bone density, and lack of exercise.

Currently, the osteoarthritis can be diagnosed with the physical examination and with the help of an x-ray, MRI, CT scan, and arthroscopy. Therapeutics for the osteoarthritis is mostly given on the basis of symptoms and pain. The treatment of osteoarthritis involves treatment associated with the pain, corticosteroid injections, viscosupplementation with intra-articular hyaluronate injections, and nonsteroidal anti-inflammatory drugs. In addition to this, over the counter drugs such as ibuprofen (Advil, Motrin IB, others) and naproxen sodium (Aleve, others) are also taken for the treatment of the osteoarthritis. Some analgesics also prescribe by the doctor to relieve the pain; however, it does not work to reduce the inflammation. Furthermore, there are also a lot of creams and ointments are available in the market to apply on the joints, which helps to reduce the pain.  People have become very conscious about their health, people no longer avoid diseases, rather they get them treated immediately, hence osteoarthritis and many other problems like it can be cured by getting timely treatment.

Osteoarthritis Therapeutics Market Size

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers
  • Increasing prevalence of osteoarthritis across the globe

The increasing prevalence of osteoarthritis is one of the key driving factors for the growth of osteoarthritis therapeutics treatment market. For instance, osteoarthritis affects more than 240 million people globally. In addition to this, more than 100 million people in the U.S. have been affected by the osteoarthritis, of which 40 million are suffering from knee osteoarthritis. Obesity and high body mass index are some of the factors that offer a greater risk of osteoarthritis. Thus, the rising prevalence of osteoarthritis across the globe, the demand for osteoarthritis therapeutics is increasing.

  • Rising incidences of sports injuries

Common sports injuries such as sprains, knee injuries, cartilage tears, fractures and dislocations can trigger the osteoarthritis after some years. Osteoarthritis starts to develop after braking the soft tissues which protect the joint. The risk of cartilage trouble increases after sports injuries. The sports injuries can lead up to 10%-15% osteoarthritis cases. Thus, rising sports injuries driving the growth of the market.

Restraints:
  • Adverse side effects of osteoarthritis therapeutics drugs

Osteoarthritis therapeutics drugs offer pain relief and reduced inflammation. However, the various drugs which is used for the treatment of osteoarthritis exhibit some kind of side effects. The side effects can be mild as well as severe. Some of the side effects include gas, heartburn, diarrhoea, dizziness, and vomiting. Thus, the adverse side effects of osteoarthritis therapeutics drugs may hamper the growth of the market.

Opportunities:
  • Increasing awareness about osteoarthritis therapeutics in emerging market

Osteoarthritis is one of the most common problems in developing countries. For instance, in India, osteoarthritis is the second common rheumatologic disorder with a prevalence of 22% to 39%. In the past few years, there was a lack of awareness about the treatment available for the osteoarthritis. However, with the increasing awareness and rising healthcare, many patients are opting for the osteoarthritis therapeutics treatment. Thus, increasing awareness in emerging countries is likely to offer new opportunities in the market.

Challenges:
  • Availability of non-drug therapies for the osteoarthritis

Availability of non-drug therapies for the osteoarthritis is one of the key challenges in the global market. Some of the non-drug therapies are exercise, acupuncture, and massage therapy. In recent years the non-drug therapies have gained popularity as it does not have any side effects. Furthermore, therapies are cost-effective than drug treatment. Thus, the rising preference for non-drug therapies is projected to hamper the growth of the market.

Segmentation Analysis:

The global osteoarthritis therapeutics market has been segmented based on drug type, anatomy, route of administration, distribution channel, and regions.

  • The drug type segment is divided into viscosupplementation agent, nonsteroidal anti-inflammatory drugs, analgesics, corticosteroids, and others. Viscosupplementation agent dominated the global osteoarthritis therapeutics market and held the market share of 45.26% in the year 2023. This drug is highly used for the knee joint to relieve the pain associated with the osteoarthritis. Thus, the high prevalence of knee osteoarthritis driving the growth of viscosupplementation agent therapeutics.
  • The anatomy segment includes knee, hip, hand, and small joints (foot & ankle and wrist). The knee joints segment is projected to grow at the highest CAGR of 8.1% over the forecast period. This is mainly due to the large number of people who are mostly suffering from the knee associated arthritis across the globe.
  • The route of administration segment includes parenteral, topical, and oral. The parenteral segment accounted for the major market share of 51% in the year 2023. Parenteral route of administration is one of the most common routes of administration which is used for the osteoarthritis drug delivery.
  • The distribution channel segment classified into hospital pharmacies, retail pharmacies, and online pharmacies. Online pharmacy segment is anticipated to grow at the highest CAGR of 8.5% over the forecast period. Increasing the patient’s preference for online pharmacies due to doorstep delivery is driving the growth of the market.
Regional segmentation analysis:

The regions analyzed for the global osteoarthritis therapeutics market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. The Europe region accounted for the major market share of 46.42% in the year 2023.

Europe Osteoarthritis Therapeutics Market Share in 2023 - 46.42%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • Increasing prevalence of osteoarthritis in the European region is one of the key contributing factors for the growth of the market. In addition to this, increasing geriatric population in countries such as Germany, Italy, and the UK, further driving the growth of the market. Furthermore, the rising obesity rate among the populations in the European countries, further boosting the growth of the market.
  • The Asia Pacific region is projected to grow at the highest CAGR of 9.4% over the forecast period. Increasing awareness about the osteoarthritis therapeutics in the region is one of the primary factor driving the growth of the market. In addition to this, the rising geriatric population in the countries such as Japan and South Korea further boosting the demand for osteoarthritis therapeutics in the Asia Pacific region. 
Competitive Analysis:

The key players of global osteoarthritis therapeutics market are majorly focusing on adoption of various strategies such as new product development, joint venture, collaboration, technological integration, product innovations, mergers & acquisitions, and partnerships to gain the significant market share in the industry.

In July 2019, GlaxoSmithKline Plc announced the start of a phase III clinical development programme with otilimab, an anti GM-CSF monoclonal antibody, for the patient who are suffering from moderate to severe arthritis.

In February 2018, Anika Therapeutics announced the partnership with the Institute of Integrative Biology at the University of Liverpool for the development of innovative therapy for osteoarthritis.

List of Key Market Players:
  • Horizon Therapeutics
  • Sanofi
  • Pfizer
  • Bayer AG
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Abbott
  • Anika Therapeutics
  • Eli Lilly
  • Flexion Therapeutics
Key Target Audience
  • Pharmaceutical companies
  • Biotechnological institutes
  • Research and Development (R&D) Companies
  • Medical Research Laboratories
  • Market Research and Consulting Service Providers
  • Government Bodies
  • Investors/Shareholders

Report Description:

  • Global Osteoarthritis Therapeutics Market, Industry Analysis, Trends, Analysis and Forecast, 2024 to 2033 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2023 is considered as the base year of the report. 2020 to 2022 are considered as the historic years and 2024 to 2033 are the forecast years. The global osteoarthritis therapeutics market is based on revenue (USD Million/Billion). The report incorporates the market study on the basis of revenue. The study covers the market share revenue/market share for each of the segments, regions and countries catering to global osteoarthritis therapeutics market. The regions analyzed for the market are Europe, Asia Pacific, North America, South America and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts all across the globe. The research report also delivers an outline of the attractiveness of osteoarthritis therapeutics and regions which are deduced and formulated on the basis of their growth rate (CAGR), market size, and attractiveness by analyzing the present and future prospects to market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to global osteoarthritis therapeutics market. This offers vital and in depth insights in order to depict the overall market scenario.
  • The report offers the detailed study for the company profiles of key organizations operating in the global osteoarthritis therapeutics market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development &innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario. 
  • The report provides an elaborative assessment of the porter’s five forces analysis coupled with SWOT analysis so as to provide business related data and information’s. Porter’s five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company growth and development in order to sustain and survive in the long run.
  • Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which act as a key potential for the investors. 
  • Potential growth prospects along with the penetration rate analysis of the products (market related i.e., global osteoarthritis therapeutics market is covered in order to comprehend the adoption rate and evaluate the market size.

Frequesntly Asked Questions

As per The Brainy Insights, the size of the osteoarthritis therapeutics market was valued at USD 9.76 billion in 2023 to reach USD 21.77 billion by 2033.

Global osteoarthritis therapeutics market is growing at a CAGR of 8.35% during the forecast period 2024-2033.

The Europe region emerged as the largest market for the osteoarthritis therapeutics.

Increasing prevalence of osteoarthritis disease across the globe is one of the key factors driving the demand for osteoarthritis therapeutics from the past few years.

Adverse side effects of osteoarthritis drugs may limit the growth of the market over the forecast period.

Increasing awareness about osteoarthritis therapeutics in emerging market is one of the key growth opportunities in the market.

Key players are Horizon Therapeutics, Sanofi, Pfizer, Bayer AG, GlaxoSmithKline Plc, Johnson & Johnson, Abbott, Anika Therapeutics, Eli Lilly, and Flexion Therapeutics among others.

Get Your Report Customized

  • Further segmentation of the market on the basis of type, application, end use, product, technology, method, process and any other segment depending on the market
  • Segmentation on the basis of any specific country or region
  • Any segment can be classified on the basis of application
  • Application segment can be further divided on the basis of companies
  • The companies profiled are not limited, we can incorporate additional companies of your choice
  • We can split the company market share on the basis of product, application and region
  • Report can be prepared for any specific country/region/segment
  • Customers can be added on the basis of regions and countries
Request for Customization

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Drug Type
          4.3.2. Market Attractiveness Analysis By Anatomy
          4.3.3. Market Attractiveness Analysis By Route of Administration
          4.3.4. Market Attractiveness Analysis By Distribution Channel
          4.3.5. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing prevalence of osteoarthritis across the globe
          5.2.2. Rising incidences of sports injuries
    5.3. Restrains
          5.3.1. Adverse side effects of osteoarthritis therapeutics drugs
    5.4. Opportunities
          5.4.1. Increasing awareness about osteoarthritis therapeutics in emerging market
    5.5. Challenges
          5.5.1. Availability of non-drug therapies for the osteoarthritis



6. Global Osteoarthritis Therapeutics Market Analysis and Forecast, By Drug Type
    6.1. Segment Overview
    6.2. Macrobrewery Equipment
    6.3. Viscosupplementation Agents
    6.4. Nonsteroidal Anti-inflammatory Drugs
    6.5. Analgesics
    6.6. Corticosteroids
    6.7. Others

7. Global Osteoarthritis Therapeutics Market Analysis and Forecast, By Anatomy
    7.1. Segment Overview
    7.2. Knee
    7.3. Hip
    7.4. Hand
    7.5. Small Joints

8. Global Osteoarthritis Therapeutics Market Analysis and Forecast, By Route of Administration
    8.1. Segment Overview
    8.2. Parenteral
    8.3. Topical
    8.4. Oral

9. Global Osteoarthritis Therapeutics Market Analysis and Forecast, By Distribution Channel
    9.1. Segment Overview
    9.2. Hospital Pharmacies
    9.3. Retail Pharmacies
    9.4. Online Pharmacies

10. Global Osteoarthritis Therapeutics Market Analysis and Forecast, By Regional Analysis
    10.1. Segment Overview
    10.2. North America
          10.2.1. U.S.
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Europe
          10.3.1. Germany
          10.3.2. France
          10.3.3. U.K.
          10.3.4. Italy
          10.3.5. Spain
    10.4. Asia-Pacific
          10.4.1. Japan
          10.4.2. China
          10.4.3. India
    10.5. South America
          10.5.1. Brazil
    10.6. Middle East and Africa
          10.6.1. UAE
          10.6.2. South Africa

11. Global Osteoarthritis Therapeutics Market-Competitive Landscape
    11.1. Overview
    11.2. Market Share of Key Players in Global Osteoarthritis Therapeutics Market
          11.2.1. Global Company Market Share
          11.2.2. North America Company Market Share
          11.2.3. Europe Company Market Share
          11.2.4. APAC Company Market Share
    11.3. Competitive Situations and Trends
          11.3.1. Product Launches and Developments
          11.3.2. Partnerships, Collaborations, and Agreements
          11.3.3. Mergers & Acquisitions
          11.3.4. Expansions

12. Company Profiles
    12.1. Horizon Therapeutics
          12.1.1. Business Overview
          12.1.2. Company Snapshot
          12.1.3. Company Market Share Analysis
          12.1.4. Company Product Portfolio
          12.1.5. Recent Developments
          12.1.6. SWOT Analysis
    12.2. Sanofi
          12.2.1. Business Overview
          12.2.2. Company Snapshot
          12.2.3. Company Market Share Analysis
          12.2.4. Company Product Portfolio
          12.2.5. Recent Developments
          12.2.6. SWOT Analysis
    12.3. Pfizer
          12.3.1. Business Overview
          12.3.2. Company Snapshot
          12.3.3. Company Market Share Analysis
          12.3.4. Company Product Portfolio
          12.3.5. Recent Developments
          12.3.6. SWOT Analysis
    12.4. Bayer AG
          12.4.1. Business Overview
          12.4.2. Company Snapshot
          12.4.3. Company Market Share Analysis
          12.4.4. Company Product Portfolio
          12.4.5. Recent Developments
          12.4.6. SWOT Analysis
    12.5. GlaxoSmithKline Plc
          12.5.1. Business Overview
          12.5.2. Company Snapshot
          12.5.3. Company Market Share Analysis
          12.5.4. Company Product Portfolio
          12.5.5. Recent Developments
          12.5.6. SWOT Analysis
    12.6. Johnson & Johnson
          12.6.1. Business Overview
          12.6.2. Company Snapshot
          12.6.3. Company Market Share Analysis
          12.6.4. Company Product Portfolio
          12.6.5. Recent Developments
          12.6.6. SWOT Analysis
    12.7. Abbott
          12.7.1. Business Overview
          12.7.2. Company Snapshot
          12.7.3. Company Market Share Analysis
          12.7.4. Company Product Portfolio
          12.7.5. Recent Developments
          12.7.6. SWOT Analysis
    12.8. Anika Therapeutics
          12.8.1. Business Overview
          12.8.2. Company Snapshot
          12.8.3. Company Market Share Analysis
          12.8.4. Company Product Portfolio
          12.8.5. Recent Developments
          12.8.6. SWOT Analysis
    12.9. Eli Lilly
          12.9.1. Business Overview
          12.9.2. Company Snapshot
          12.9.3. Company Market Share Analysis
          12.9.4. Company Product Portfolio
          12.9.5. Recent Developments
          12.9.6. SWOT Analysis
    12.10. Flexion Therapeutics
          12.10.1. Business Overview
          12.10.2. Company Snapshot
          12.10.3. Company Market Share Analysis
          12.10.4. Company Product Portfolio
          12.10.5. Recent Developments
          12.10.6. SWOT Analysis

List of Table

1. Global Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

2. Global Viscosupplementation Agents, Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

3. Global Nonsteroidal Anti-inflammatory Drugs, Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

4. Global Analgesics, Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

5. Global Corticosteroids, Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

6. Global Others, Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

7. Global Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

8. Global Knee, Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

9. Global Hip, Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

10. Global Hand, Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

11. Global Small Joints, Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

12. Global Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

13. Global Parenteral Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

14. Global Topical Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

15. Global Oral Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

16. Global Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

17. Global Retail Pharmacies Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

18. Global Online Pharmacies Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

19. Global Hospital Pharmacies Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

20. Global Osteoarthritis Therapeutics Market, By Region, 2020–2033(USD Billion)

21. North America Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

22. North America Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

23. North America Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

24. North America Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

25. U.S. Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

26. U.S. Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

27. U.S. Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

28. U.S. Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

29. Canada Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

30. Canada Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

31. Canada Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

32. Canada Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

33. Mexico Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

34. Mexico Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

35. Mexico Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

36. Mexico Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

37. Europe Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

38. Europe Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

39. Europe Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

40. Europe Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

41. Germany Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

42. Germany Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

43. Germany Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

44. Germany Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

45. France Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

46. France Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

47. France Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

48. France Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

49. U.K. Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

50. U.K. Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

51. U.K. Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

52. U.K. Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

53. Italy Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

54. Italy Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

55. Italy Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

56. Italy Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

57. Spain Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

58. Spain Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

59. Spain Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

60. Spain Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

61. Asia Pacific Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

62. Asia Pacific Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

63. Asia Pacific Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

64. Asia Pacific Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

65. Japan Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

66. Japan Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

67. Japan Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

68. Japan Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

69. China Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

70. China Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

71. China Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

72. China Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

73. India Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

74. India Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

75. India Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

76. India Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

77. South America Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

78. South America Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

79. South America Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

80. South America Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

81. Brazil Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

82. Brazil Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

83. Brazil Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

84. Brazil Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

85. Middle East and Africa Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

86. Middle East and Africa Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

87. Middle East and Africa Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

88. Middle East and Africa Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

89. UAE Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

90. UAE Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

91. UAE Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

92. UAE Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

93. South Africa Osteoarthritis Therapeutics Market, By Drug Type, 2020–2033(USD Billion)

94. South Africa Osteoarthritis Therapeutics Market, By Anatomy, 2020–2033(USD Billion)

95. South Africa Osteoarthritis Therapeutics Market, By Route of Administration, 2020–2033(USD Billion)

96. South Africa Osteoarthritis Therapeutics Market, By Distribution Channel, 2020–2033(USD Billion)

List of Figures 

1. Global Osteoarthritis Therapeutics Market Segmentation

2. Osteoarthritis Therapeutics Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Osteoarthritis Therapeutics Market Attractiveness Analysis By Drug Type

9. Global Osteoarthritis Therapeutics Market Attractiveness Analysis By Anatomy

10. Global Osteoarthritis Therapeutics Market Attractiveness Analysis By Route of Administration

11. Global Osteoarthritis Therapeutics Market Attractiveness Analysis By Distribution Channel

12. Global Osteoarthritis Therapeutics Market Attractiveness Analysis By Region

13. Global Osteoarthritis Therapeutics Market: Dynamics

14. Global Osteoarthritis Therapeutics Market Share By Drug Type (2023 & 2033)

15. Global Osteoarthritis Therapeutics Market Share By Anatomy (2023 & 2033)

16. Global Osteoarthritis Therapeutics Market Share By Route of Administration (2023 & 2033)

17. Global Osteoarthritis Therapeutics Market Share By Distribution Channel (2023 & 2033)

18. Global Osteoarthritis Therapeutics Market Share by Regions (2023 & 2033)

19. Global Osteoarthritis Therapeutics Market Share by Company (2023)

This study forecasts revenue and volume growth at global, regional, and country levels from 2020 to 2033. The Brainy Insights has segmented the global osteoarthritis therapeutics market on the basis of below mentioned segments:

Global Osteoarthritis Therapeutics Market by Anatomy:

  • Knee
  • Hip
  • Hand
  • Small Joints (Foot & Ankle and Wrist )

Global Osteoarthritis Therapeutics Market by Drug Type:

  • Viscosupplementation Agents
  • Nonsteroidal Anti-inflammatory Drugs
  • Analgesics
  • Corticosteroids
  • Others

Global Osteoarthritis Therapeutics Market by Route of Administration:

  • Parenteral
  • Topical
  • Oral

 Global Osteoarthritis Therapeutics Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Osteoarthritis therapeutics Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Ask for customization Request Sample Speak to analyst Inquire before buying

Flexible Purchase Options

  • Chapters of your choice
  • Quantitative Information for Historical & Forecasted Data
  • Regional/Country Level Reports
Request for Special Pricing

Get in touch with us

+1-315-215-1633

sales@thebrainyinsights.com

Our Clients

Why choose us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date